Management of chronic uveitis.
作者信息
McCluskey P J, Towler H M, Lightman S
机构信息
Department of Ophthalmology, St Vincent's Hospital, Sydney, NSW, Australia.
出版信息
BMJ. 2000 Feb 26;320(7234):555-8. doi: 10.1136/bmj.320.7234.555.
Abstract
摘要
相似文献
1
Management of chronic uveitis.慢性葡萄膜炎的管理
BMJ. 2000 Feb 26;320(7234):555-8. doi: 10.1136/bmj.320.7234.555.
2
[Traumatic uveitis: the problem of pathogenetic therapy].
Vestn Oftalmol. 1998 Mar-Apr;114(2):53-6.
3
[Etiological diagnosis of uveitis and therapeutic management].[葡萄膜炎的病因诊断与治疗管理]
Bull Soc Ophtalmol Fr. 1976 Sep-Oct;76(9-10):839-46.
4
Uveitis management: a multidisciplinary approach to assess systemic involvement and side effects of treatments.葡萄膜炎的管理：一种评估全身受累情况及治疗副作用的多学科方法。
Acta Clin Belg. 2002 Jun-Jul;57(3):142-7. doi: 10.1179/acb.2002.030.
5
Investigation and management of uveitis.葡萄膜炎的检查与治疗
BMJ. 2010 Oct 13;341:c4976. doi: 10.1136/bmj.c4976.
6
The uvea.葡萄膜。
Arch Ophthalmol. 1972 Jun;87(6):713-25. doi: 10.1001/archopht.1972.01000020715019.
7
Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.幼年型贝赫切特病的葡萄膜炎：与成年患者比较的临床病程和视力结局。
Eye (Lond). 2009 Nov;23(11):2034-41. doi: 10.1038/eye.2008.397. Epub 2009 Jan 16.
8
[Uveitis in children: about 20 cases].[儿童葡萄膜炎：约20例]
J Fr Ophtalmol. 2003 Jun;26(6):609-13.
9
[Therapy of intermediate uveitis].[中间葡萄膜炎的治疗]
Ophthalmologe. 2014 Dec;111(12):1219-32; quiz 1233-4. doi: 10.1007/s00347-014-3201-2.
10
Management of Uveitis in Spondyloarthropathy: Current Trends.脊柱关节炎相关葡萄膜炎的管理：当前趋势
Perm J. 2018;22:17-041. doi: 10.7812/TPP/17-041.
引用本文的文献
1
Neural networks for predicting etiological diagnosis of uveitis.用于预测葡萄膜炎病因诊断的神经网络。
Eye (Lond). 2025 Apr;39(5):992-1002. doi: 10.1038/s41433-024-03530-2. Epub 2024 Dec 20.
2
Causal relationship between ankylosing spondylitis and ocular inflammatory diseases: a Mendelian randomization study.强直性脊柱炎与眼部炎症性疾病之间的因果关系：一项孟德尔随机化研究。
Front Genet. 2024 Oct 17;15:1372196. doi: 10.3389/fgene.2024.1372196. eCollection 2024.
3
Efficacy and safety of single-dose intravitreal dexamethasone implant in non-infectious uveitic macular edema: A systematic review and meta-analysis.单剂量玻璃体内注射地塞米松植入物治疗非感染性葡萄膜炎性黄斑水肿的疗效和安全性：一项系统评价和荟萃分析。
Front Med (Lausanne). 2023 Feb 17;10:1126724. doi: 10.3389/fmed.2023.1126724. eCollection 2023.
4
Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis.用于非感染性葡萄膜炎的新型玻璃体内治疗药物的疗效和安全性比较：一项系统评价和网状Meta分析
Front Pharmacol. 2022 Apr 5;13:749312. doi: 10.3389/fphar.2022.749312. eCollection 2022.
5
Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study.复发性非感染性前葡萄膜炎中循环生物标志物的特征。二十二碳六烯酸甘油三酯的免疫调节作用。一项初步研究。
Diagnostics (Basel). 2021 Apr 19;11(4):724. doi: 10.3390/diagnostics11040724.
6
Metabolomic Analysis of Aqueous Humor Identifies Aberrant Amino Acid and Fatty Acid Metabolism in Vogt-Koyanagi-Harada and Behcet's Disease.房水的代谢组学分析揭示了葡萄膜炎和贝赫切特病中异常的氨基酸和脂肪酸代谢。
Front Immunol. 2021 Feb 22;12:587393. doi: 10.3389/fimmu.2021.587393. eCollection 2021.
7
Characterization of Clinical and Immune Responses in an Experimental Chronic Autoimmune Uveitis Model.实验性慢性自身免疫性葡萄膜炎模型中的临床和免疫反应特征。
Am J Pathol. 2021 Mar;191(3):425-437. doi: 10.1016/j.ajpath.2020.09.004. Epub 2020 Sep 20.
8
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.眼科中的皮质类固醇：药物输送创新、药理学、临床应用和未来展望。
Drug Deliv Transl Res. 2021 Jun;11(3):866-893. doi: 10.1007/s13346-020-00843-z.
9
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW.培塞利珠单抗治疗对轴性脊柱关节炎患者前葡萄膜炎发作发生率的影响：C-VIEW 的 48 周中期结果。
RMD Open. 2020 Apr;6(1). doi: 10.1136/rmdopen-2019-001161.
10
Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy.阿达木单抗治疗后难治性非感染性葡萄膜炎患者的眼内炎症控制及视网膜和脉络膜结构变化
J Clin Med. 2020 Feb 13;9(2):510. doi: 10.3390/jcm9020510.
本文引用的文献
1
Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis.原发性小梁切除术联合 5- 氟尿嘧啶治疗葡萄膜炎继发青光眼。
Ocul Immunol Inflamm. 1995;3(3):163-70. doi: 10.3109/09273949509069109.
2
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.人源化抗Tac单克隆抗体治疗非感染性中间葡萄膜炎和后葡萄膜炎：一项I/II期临床试验。
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7462-6. doi: 10.1073/pnas.96.13.7462.
3
Assessment of visual outcome after cataract surgery in patients with uveitis.葡萄膜炎患者白内障手术后视觉预后的评估。
Ophthalmology. 1999 Apr;106(4):710-22. doi: 10.1016/S0161-6420(99)90155-0.
4
Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.霉酚酸酯。一种用于炎性眼病的有效免疫抑制剂。
Ophthalmology. 1999 Feb;106(2):370-4. doi: 10.1016/S0161-6420(99)90078-7.
5
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.玻璃体内缓释环孢素治疗实验性葡萄膜炎。
Ophthalmology. 1998 Jan;105(1):46-56. doi: 10.1016/s0161-6420(98)91176-9.
6
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial.口服视网膜抗原治疗葡萄膜炎：一项I/II期随机双盲试验的结果
Am J Ophthalmol. 1997 May;123(5):583-92. doi: 10.1016/s0002-9394(14)71070-0.
7
Ocular tuberculosis. A prospective study in a general hospital.
Medicine (Baltimore). 1997 Jan;76(1):53-61. doi: 10.1097/00005792-199701000-00005.
8
The possible impact of uveitis in blindness: a literature survey.葡萄膜炎对失明的潜在影响：一项文献综述。
Br J Ophthalmol. 1996 Sep;80(9):844-8. doi: 10.1136/bjo.80.9.844.
9
Causes and frequency of blindness in patients with intraocular inflammatory disease.眼内炎性疾病患者失明的原因及发生率
Br J Ophthalmol. 1996 Apr;80(4):332-6. doi: 10.1136/bjo.80.4.332.
10
An intravitreal device providing sustained release of cyclosporine and dexamethasone.一种提供环孢素和地塞米松持续释放的玻璃体内装置。
Curr Eye Res. 1996 May;15(5):549-57. doi: 10.3109/02713689609000766.
Zotero 插件